Amiodarone therapy

Acquired cataract - Amiodarone therapy Factor

Amiodarone therapy is used for treatment of severe cardiac arrhythmias that are unresponsive to other therapies.  Hospitalisation is required for amiodarone therapy.  Brand names include Aratac, Cordarone and Pacerone.

Last reviewed for CCPS 20 August 2008.

Investigative Documents

Preliminary questions [30926]

31041 there is some evidence that amiodarone therapy may be a factor in the development or worsening of the condition under consideration.

31017 the condition under consideration is an anterior subcapsular cataract.

31042 the veteran has received amiodarone therapy for a cumulative period of at least 180 days at some time.

31043 the amiodarone therapy for a cumulative period of at least 180 days was materially contributed to by treatment of an illness or injury which is identifiable.

31044  the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and VEA service for acquired cataract.

31045   the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and VEA service for the clinical onset of acquired cataract.

31047  the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and eligible service for the clinical onset of acquired cataract.

or

31048  the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and operational service for the clinical onset of acquired cataract.

or

7334     the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335     the condition under consideration permanently worsened.

31046   the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and VEA service for the clinical worsening of acquired cataract.

31049  the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and eligible service for the clinical worsening of acquired cataract.

or

31050  the veteran has established the causal connection between the identified illness or injury for which amiodarone therapy was given and operational service for the clinical worsening of acquired cataract.

Clinical onset and operational service [31048]

31052 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 180 days before the clinical onset of the condition under consideration.

31057  the identified illness or injury which made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 180 days is causally related to operational service.

Clinical onset and eligible service [31047]

31051 the veteran has received amiodarone therapy for a cumulative period of at least 365 days at some time.

31054 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days.

31055 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days before the clinical onset of the condition under consideration.

31059  the identified illness or injury which made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days is causally related to eligible service.

Clinical worsening and operational service [31050]

31053 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 180 days before the clinical worsening of the condition under consideration.

31057  the identified illness or injury which made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 180 days is causally related to operational service.

31061 the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury that materially contributed to amiodarone therapy for a cumulative period of at least 180 days is causally related.

Clinical worsening and eligible service [31049]

31051 the veteran has received amiodarone therapy for a cumulative period of at least 365 days at some time.

31054 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days.

31056 the identified illness or injury made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days before the clinical worsening of the condition under consideration.

31059  the identified illness or injury which made a material contribution to the veteran receiving amiodarone therapy for a cumulative period of at least 365 days is causally related to eligible service.

31062 the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury that materially contributed to amiodarone therapy for a cumulative period of at least 365 days is causally related.